Xu L

No ORCID on file · 150 papers in corpus · active 2008-2026

Study types

  • article 31
  • other 9
  • review 8
  • preprint 5
  • case-report 3

Condition tags

  • endometriosis 39
  • adenomyosis 18
  • dysmenorrhea 8
  • chronic_pelvic_pain 7
  • infertility 4
  • dyspareunia 4
  • endometrioma 2
Frontiers in endocrinology
2026
Frontiers in immunology ·doi:10.3389/fimmu.2026.1795144

BackgroundOvarian cancer remains one of the deadliest gynecologic malignancies. Poor outcomes largely reflect late diagnosis, marked inter- and intratumoral heterogeneity, and variable treatment response.MethodsThis review summarizes recent…

2026
BMC pregnancy and childbirth ·doi:10.1186/s12884-026-08661-w

OBJECTIVE: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is primarily characterized by neonatal jaundice and acute/chronic hemolytic anemia. This study aimed to examine the influence of different G6PD genotypes on pregnancy and neonat…

article 2026
Frontiers in medicine ·doi:10.3389/fmed.2026.1776698

OBJECTIVE: To systematically evaluate the efficacy and safety of blood-invigorating and stasis-resolving Chinese herbal medicines (BISMs) when combined with conventional clinical therapy for endometriosis, and to provide evidence-based guid…

preprint 2026
·doi:10.21203/rs.3.rs-8294770/v1

Abstract Background Synchronous multiple primary malignancies (SMPMs) of the uterus and ovary are uncommon and diagnostically challenging, as they must be distinguished from metastatic spread of a single primary tumor. Accurate assessme…

other 2026
Expert opinion on drug safety ·doi:10.1080/14740338.2024.2446414

OBJECTIVES: Medroxyprogesterone acetate (MPA), a steroid progesterone, is widely used to treat endometriosis, menstrual disorders, and uterine bleeding in clinical practice. However, the safety profile of MPA requires comprehensive evaluati…

case-report 2026
BMC women's health ·doi:10.1186/s12905-026-04415-0

BACKGROUND: Synchronous multiple primary malignancies (SMPMs) involving the uterus and ovary pose significant diagnostic challenges, particularly in distinguishing independent primary tumors from metastatic disease when tumors exhibit overl…

other 2026
Molecular imaging and biology ·doi:10.1007/s11307-026-02086-9

Endometriosis diagnosis is often limited by the resolution of conventional imaging techniques (ultrasound/non-targeted MRI) as well as the invasiveness and recurrence risks associated with laparoscopy. To overcome these challenges, we devel…

other 2026
Journal of controlled release : official journal of the Controlled Release Society ·doi:10.1016/j.jconrel.2026.115007

Fibroblast growth factor receptor 2 (FGFR2) has emerged as a highly promising therapeutic target due to its critical role in the pathogenesis and progression of endometriosis. To date, a variety of FGFR2 inhibitors have exhibited remarkable…

2026
Functional & integrative genomics ·doi:10.1007/s10142-026-01888-y

Endometriosis is a common, chronic gynecological disorder characterized by the presence of endometrial-like tissue outside the uterine cavity, frequently associated with significant morbidities such as pelvic pain and infertility. Elucidati…

2026
Communications biology ·doi:10.1038/s42003-026-09615-w

Pregnant women undergoing assisted reproductive technology (ART) have an increased risk of gestational diabetes mellitus (GDM), potentially linked to altered immune regulation, but the underlying circulating immune features remain unclear. …

other 2026
Redox biology ·doi:10.1016/j.redox.2026.104101

Endometriosis (EM) is driven by immune dysregulation and macrophage dysfunction, yet the underlying mechanisms remain unclear. Here, metabolomic profiling revealed excessive itaconate accumulation in EM lesions, primarily due to elevated ci…

2026
Bioactive materials ·doi:10.1016/j.bioactmat.2026.03.041

Biofilm accumulation and subsequent implant-related infections pose significant challenges in the biomedical field. Photocatalytic coatings hold promise for antimicrobial efficacy; however, their effectiveness in dynamic polymicrobial infec…

2026
Frontiers in endocrinology ·doi:10.3389/fendo.2026.1846830

PurposeTo investigate the impact of regressed endometrial hyperplasia (EH) on assisted reproductive technology outcomes, particularly in comparison with infertile women with a relatively normal endometrium.MethodsThis retrospective study in…

review 2026
Seminars in immunopathology ·doi:10.1007/s00281-026-01077-w

Adenomyosis is a common and difficult disease in gynecology. Its main clinical manifestations include uterine hypertrophy, excessive menstruation, pelvic pain and infertility, which have a serious impact on women's health. Seriously affects…

other 2026
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-025-03781-2

PURPOSE: Endometriosis (EM) is a chronic inflammatory gynecological disorder characterized by ectopic endometrial-like lesions, where aberrant angiogenesis is a hallmark driving lesion establishment and progression. However, the transcripti…

2025
Clinical cancer research : an official journal of the American Association for Cancer Research ·doi:10.1158/1078-0432.ccr-25-0816

PurposeARID1A, encoding a component of the switch/sucrose nonfermentable complex, is frequently mutated in urothelial carcinoma. However, its specific impacts on clinical outcomes and CD8+ T-cell functions in urothelial carcinoma remain poo…

article 2025
Journal of reproductive immunology ·doi:10.1016/j.jri.2025.104630

This study investigated the role of ACSL4 in endometrial receptivity disorders in endometriosis (EMs) and evaluated PRGL493, an ACSL4 inhibitor, as a potential therapeutic target. Bioinformatic analysis identified ACSL4 as a potential key r…

2025
World journal of gastrointestinal oncology ·doi:10.4251/wjgo.v17.i1.99376

BackgroundEsophageal squamous cell carcinoma (ESCC) is a malignant tumor with high morbidity and mortality, and easy to develop resistance to chemotherapeutic agents. Telomeres are DNA-protein complexes located at the termini of chromosomes…

article 2025
Medicine ·doi:10.1097/md.0000000000043163

Endometriosis (EMS) is a complex gynecological disorder whose pathogenesis remains poorly understood, with lipid metabolism, immune regulation, and inflammation likely playing pivotal roles. This Mendelian randomization study investigates c…

2025
Frontiers in immunology ·doi:10.3389/fimmu.2025.1719669

Ovarian cancer(OC) poses a significant clinical challenge due to its frequent peritoneal dissemination and development of chemotherapy resistance, contributing to poor patient outcomes. Chronic inflammation is a pivotal driver of disease in…

article 2025
Archives of gynecology and obstetrics ·doi:10.1007/s00404-025-08025-3

OBJECTIVE: To evaluate the clinicopathologic characteristics and survival outcomes of ovarian clear cell carcinoma (OCCC) patients with different endometriosis statuses. METHODS: This retrospective study included OCCC patients diagnosed be…

2025
Frontiers in medicine ·doi:10.3389/fmed.2025.1617194

ObjectiveThis study aimed to compare the perioperative outcomes of single-incision laparoscopic surgery (SILS) and dual-port laparoscopic myomectomy in patients with solitary uterine fibroids.MethodsThis retrospective observational study in…

2025
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-025-01504-x

BackgroundMore than 500 patients have received cryopreserved ovarian tissue transplantation (OTT) worldwide, resulting in over 200 live births. Although guidelines recognize OTT as an effective fertility preservation method, there is no con…

2025
Frontiers in endocrinology ·doi:10.3389/fendo.2025.1692746

BackgroundDiabetes mellitus (DM) is one of the most common endocrine disorders affecting various physiological systems and tissues, including the reproductive organs in men. However, the consequences of DM for male individuals undergoing as…